Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo  by Connolly, E.M. et al.
Pharmacological Induction of HSP27 Attenuates
Intimal Hyperplasia In Vivo
E. M. Connolly1, C. J. Kelly1, Gang Chen1, T. O'Grady2, E. Kay2, A. Leahy1
and D. J. Bouchier-Hayes1
Departments of 1Surgery and 2Pathology, Education and Research Center, Royal College of Surgeons in Ireland,
Beaumont Hospital, Beaumont Rd, Dublin 9, Ireland
Objectives: intimal hyperplasia (IH) is a major cause of re-stenosis post-vascular intervention. Induction of heat shock
proteins (HSPs), by thermal pre-conditioning, reduces IH. Our aim was to investigate the effect of the pharmacological
HSP inducer herbimycin A on IH in the rat carotid balloon injury model.
Materials and Methods: thirty male Sprague±Dawley rats were randomized into three groups. All groups underwent
balloon injury to the left carotid artery. Stress proteins were induced 18 h pre-operatively by heat shock or herbimycin A.
Two weeks post-operatively, animals were sacrificed and carotid intima/media area ratio (I/M ratio) calculated using
computerized planimetry. Neo-intimal proliferation was assessed immunohistochemically with PCNA (proliferating cell
nuclear antigen). Western blot and immunohistochemistry for arterial HSP70 and HSP27 were performed.
Results: heat stress and herbimycin significantly reduced the I/M ratio (p5 0.05 vs balloon injury alone). Neo-intimal
proliferation was significantly reduced in the heat stress and herbimycin groups (p5 0.05 vs balloon injury alone). Heat
stress induced arterial HSP70 and HSP27. Herbimycin A increased arterial HSP27.
Conclusion: herbimycin A significantly attenuates IH after balloon injury. HSP27 may be the HSP involved in mediating
this response. Pharmacological inducers of HSPs may have a therapeutic role to play in preventing re-stenosis post-vascular
intervention.
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Introduction
Re-stenoses secondary to intimal hyperplasia (IH)
remains the major limiting factor after vascular inter-
vention. Thirty to fifty percent of coronary and per-
ipheral arteries develop re-stenosis after angioplasty,
a rate that has changed little since the introduction
of the technique over 20 years ago.1 The recently
reported patency rates obtained with sirolimus coated
stents2 are promising but there use is limited espe-
cially in multisegment disease or distal peripheral
vascular disease.3 Arterial medial vascular smooth
muscle cell (VSMC) proliferation, resulting from
angioplasty-associated mechanical stretch injury, has
been shown to be an important contributory mechan-
ism to re-stenosis.4±6 Strategies aimed at reducing
VSMC proliferation post-injury, have had little clinical
success.7±9 The most likely explanation for the poor
efficacy of these agents is the abundance of inflamma-
tory mediators and growth factors involved in pro-
moting the hyperplastic response.10±13 Consequently,
much interest now focuses on pre-conditioning arter-
ial smooth muscle cells prior to intervention, in order
to prepare them for subsequent injury and thereby
limit the proliferation response.
Pre-conditioning is a process whereby exposure of a
cell to a sub-critical stress serves to protect it from
subsequent injury.14 Pre-conditioning is brought
about by the production of intracellular proteins
known as stress proteins or heat shock proteins
(HSP). Stress proteins are classified according to their
apparent molecular weight and respective inducers,
e.g. HSP70, HSP90 and HSP27. Heat shock proteins
can be induced in a number of ways the most studied
of which being a brief period of hyperthermia, this is
known as thermal pre-conditioning. Recent attention
has focused on pharmacological induction of HSPs.15
Herbimycin A, a benzoquinoid ansamycin antibiotic is
a known heat shock protein inducer.16±18
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Heat shock proteins play an essential role in protect-
ing cells against oxidative stress.19,20 Therefore it is
not surprising that a variety of studies have demon-
strated that HSP induction, by pre-conditioning, limit
subsequent injuries. Animal studies have shown that
the heat shock response is protective against ischae-
mia re-perfusion induced injury in the heart,20±23
small intestine,24 skeletal and diaphragmatic mus-
cle25,26 and kidney.27 Also the addition of one type of
stress may provide protection against other types of
insults, this is known as cross-tolerance. As examples,
stress proteins induced by thermotolerance may pro-
vide protection during a subsequent ischaemic injury,
or exposure to a heavy metal may provide protection
against heat or sepsis. This suggests a valuable sur-
vival strategy in the adage that a `` little stress is good''
We have previously shown that pharmacological pre-
conditioning with herbimycin A increases HSP
expression and attenuates ischaemia reperfusion
induced pulmonary injury.18
Recently thermal pre-conditioning by whole body
hyperthermia has been shown to reduce IH in vivo.28
The aim of this study was to determine whether it was
possible to pre-condition arteries by pharmacological
means with herbimycin A and hence reduce intimal
hyperplasia in the rat carotid balloon injury model.
Materials and Methods
Animal preparation
All animal procedures were carried out in an
approved animal research facility, under license from
the Department of Health, Republic of Ireland. Thirty
male Sprague±Dawley rats weighing 250±320 g were
maintained on a purified chow pellet diet and water.
The rats were randomized into 3 groups: group 1:
balloon injury alone, group 2: heat shock and balloon
injury, and group 3: herbimycin A and balloon injury.
All underwent carotid balloon artery injury as
described below. Animals in group 2 were thermally
pre-conditioned, 18 h prior to balloon injury they were
anaesthetized with halothane and partially immersed
in a water bath (Grant Instruments LTD, Cambridge,
U.K.) and the core temperature gradually raised to
41 0.5 C for 15 min.18,26,27 In group 3 100 mg of
herbimycin A (H-6649, Sigma Chemical Co.) was dis-
solved in 80 ml of dimethylsulfoxide (DMSO, D-5879,
Sigma Chemical Co.) and diluted in 720 ml of normal
saline and administered 18 h prior to balloon injury by
tail vein injection.18 The animals in the other groups
received the drug vehicle by tail vein injection 18 h
prior to balloon injury.
Western blot analysis for HSP70 and HSP27
In order to determine the time of maximum HSP
expression carotid arteries and aorta from a separate
group of animals were analyzed at varying time
points after thermal pre-conditioning (0, 8, 18 and
24 h post heat shock) (n 2 at each time point).
Arteries were also harvested from non-heat stressed
rats and from rats given herbimycin A 18 h earlier
(n 2 per group). Each experiment was repeated
three times.
Harvested arteries were immediately immersed in
liquid nitrogen, pulverized with a mortar and pestle,
and suspended in a cell lysis solution. After centrifu-
gation a portion of the supernatant was used for pro-
tein concentration determination using a BCA Protein
Assay Kit (Pierce). Equal amounts of protein were then
suspended in SDS-glycerol loading buffer (pH 6.8,
62.5 mmol/Tris, 2% SDS, 10% glycerol, 5% mercap-
toethanol, 0.01% bromophenol blue) and boiled for
10 min. Equal amounts of total protein were loaded
onto a 12% and 15% polyacylamide gel, electrophor-
esed and transferred to nitrocellulose. The blots were
blocked with 5% dried-milk reagent dissolved in TBST
(1 Tris buffered saline with 0.05% Tween-20). The blot
from the 12% gel was then incubated with a murine
monoclonal anti-HSP70 antibody, SPA-810 (Stressgen,
Victoria, British Columbia), diluted 1/2000 in 5%
dried-milk reagent in TBST. A horseradish peroxidase
conjugated goat anti-mouse immunoglobulin (DAKO)
at a dilution of 1/1000, was used as the secondary
antibody. The blot was washed several times between
blocking steps with TBST. The blot from the 15% gel
was incubated with a rabbit monoclonal anti-HSP-27
antibody, SPA-801 (Stressgen, Victoria, British Columbia)
diluted to 1/2000 and a horseradish peroxidase con-
jugated goat anti-rabbit immunoglobulin (DAKO) was
used as the secondary antibody. The immunoblots
were visualized using Supersignal west pico chemi-
luminescent substrate (Pierce) and autoradiographed.
Carotid artery balloon injury model
Anesthesia was induced and maintained with
halothane. An incision was made in the anterior
neck. The method of balloon denudation was
adapted from the technique established by Clowes
et al.29 The bifurcation of the left common carotid
artery was exposed and the left common, internal
and external carotid arteries were controlled with sur-
gical ligatures. A 2Ch Fogarty catheter (Baxter
Edwards) was introduced through an arteriotomy in
the external carotid artery and advanced to the level of
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the omohyoid muscle. The balloon was inflated with
saline and drawn three times up and down
the common carotid artery, the balloon was then
deflated and withdrawn and the external carotid
artery ligated. A single trained operator preformed
all procedures.
The animals were sacrificed two weeks post-
operatively and the carotid arteries harvested. This
timepoint is used as Clowes et al.29 demonstrated that
intimal SMC number increases to a maximum 14 days
after injury and remains constant thereafter.
Evaluation of intimal hyperplasia
Fourteen days after balloon injury, the carotid arteries
were harvested, each carotid artery was excised from
the proximal edge of the omohyoid muscle to the
carotid bifurcation. The middle third of the segment
was then immersed in 10% unbuffered formalin for
fixation for 24 h. Four mm cross sections were stained
with haematoxylin and eosin. The intimal area and
medial area of each artery were obtained by compu-
terized planimetry (Samba software; Alcatel, Grenoble,
France). Neointimal thickening was quantified as the
ratio of intima to media areas (I/M ratio) from trans-
verse arterial sections. Two to four sections were
examined from each artery by an analyst blind to
the treatment regimen and the average I/M ratio
calculated.
Four mm sections of the paraffin embedded carotids,
harvested from animals, two weeks after injury, were
cut and mounted on vectabond (Vector laboratories)
coated slides and air dried at 37 C overnight. Sections
were dewaxed and rehydrated before blocking
endogenous peroxidase in 0.3% hydrogen peroxide.
Sections were then microwaved at high power in a
trisodium citrate buffer (pH 6.0) for 20 min before
incubation in mouse monoclonal antibody against
proliferating cell nuclear antigen (PCNA) (DAKO)
at 1/800 dilution in tris buffered saline (TBS) at
room temperature for 40 min. Sections were washed
in TBS and biotinylated goat anti mouse/rabbit
immunoglobulins was added followed by treatment
with streptABComplex/HRP (DAKO Duet). The
antibody-antigen reaction was visualized with dia-
minobenzidine (Sigma Chemical Co.) and sections
were lightly counterstained with Harris haematoxylin.
Tonsil was used as a positive control. The PCNA
positive and PCNA negative nuclei were counted in
the neointima and the proliferation index was
calculated by the following formula (positive nuclei
stained by PCNA/total number of nuclei stained by
haematoxylin).
Immunohistochemical localization of
heat shock proteins
Carotid arteries were harvested from rats 18 h after
heat shock, from untreated controls and from rats
pre-treated with herbimycin A (n 4 per group).
Four mm sections of paraffin embedded sections
were de-waxed, re-hydrated and endogenous perox-
idase activity blocked with hydrogen peroxide.
Sections were then incubated with goat serum diluted
in TBS (1/10 dilution) for 30 min. Sections were incu-
bated for one hour with a mouse monoclonal
antibody against HSP70, SPA-810 (Stressgen, Victoria,
British Columbia). After washing in TBS biotinylated
goat anti mouse/rabbit immunoglobulin was added
followed by treatment with streptABComplex/HRP
(DAKO). The antibody-antigen reaction was visual-
ized with diaminobenzidine (Sigma Chemical Co.)
and sections were lightly counterstained with Harris
haematoxylin. The same staining procedure was used
for staining for HSP27 using a rabbit monoclonal
antibody against HSP27, SPA-801 (Stressgen, Victoria,
British Columbia).
Statistical analysis
Results are reported as mean SEM, to test homog-
eneity of variance Bartlett's test was performed and
data was subsequently analyzed using a one way
Analysis of Variance with Tukey±Kramer multiple
comparison post hoc tests. Non parametric data was
analyzed using Kruskal±Wallis Analysis of Variance
and Dunnes multiple comparison post hoc tests.
Results
HSP70 and HSP27 protein expression in
arterial tissue
In order to determine the timing of maximal HSP
expression western blot was performed on protein
extracted from the aorta and carotid arteries at the
indicated time points after heat shock and from con-
trols (Fig. 1). HSP70 expression was maximum at
18±24 h post heat shock, with a steady decrease in
protein levels thereafter. Levels of HSP27 protein
were maximum between 8 and 18 h post heat shock
(Fig. 1). Western blot analysis was also preformed on
carotid tissue from herbimycin A pre-treated rats.
HSP27 was increased by pre-treatment with herbimy-
cin A (Fig. 2). HSP70 expression did not alter signifi-
cantly with herbimycin A treatment.
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Immunohistochemical confirmation of
HSP expression
Immunohistochemistry was preformed to confirm
results obtained by western blot and to localize pro-
tein expression within the arterial wall. HSP70 and
HSP27 were detected in the endothelium and medial
smooth muscle cells of the carotids of thermally pre-
conditioned animals (Figs 3 and 4). No significant
staining for HSP70 was detected in untreated
control carotids. Low levels of HSP27 were detected
in untreated rats. Similar to the findings with western
blot, HSP27 was present in increased amounts in the
herbimycin A pre-treated animals relative to untreat-
ed controls (Fig. 4). HSP70 expression was not altered
significantly by herbimycin A pre-treatment.
Effect of pre-conditioning on I/M ratio two weeks
after balloon injury
Animals were harvested 14 days after balloon injury
as described above. The intimal area, medial area
and I/M ratio were obtained from each artery (mean
SEM). The I/M ratio is used to analyze effects on
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Fig. 1. Western blot time course of HSP70 and HSP27 induction in
Aorta (A) and Carotid (C) at varying time points (0±24 h) post
thermal preconditioning. Both heat shock proteins were maximally
induced at 8±18 h post heat shock.
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Fig. 2. Western blot of HSP27 and HSP70 expression in rat carotid
artery in unstressed rat (control) and in rat 18 h post herbimycin A
administration.
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Fig. 3. Carotid arteries from rats given A, drug vehicle B, 18 h post
heat shock and C, from rats given herbimycin A 18 h earlier were
harvested, fixed in formalin, sectioned, and stained with a mono-
clonal anti-HSP70 antibody. The antibody was detected with an
enzyme-conjugated detection system that yields a brown colour in
positive cells. (Original magnification 400) (scale bar 50mm).
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intimal accumulation as it controls for variability
due to animal size or perfusion artifact. One-way
analysis of variance showed that the I/M ratio was
significantly lower in the heat stress (1.14 0.165) and
herbimycin A (0.87 0.19) group relative to the
untreated controls (1.84 0.2), (p5 0.05) (Figs 5 and 6).
Results of neointimal proliferation two weeks after
balloon injury
The neointimal proliferation index, as determined by
the percentage of neointimal cells staining positively
for PCNA in rat carotids two weeks after balloon
injury, was significantly (p5 0.05) lower in the heat
stressed (44.5%+ 4.07) and herbimycin A
(43.8%+ 5.38) treated animals than in the balloon
injury alone group (58.33%+ 5.13).
Discussion
Our hypothesis was that induction of arterial heat
shock proteins, with herbimycin A, in vivo, would
decrease the proliferation response of the vessel wall
to injury. This study confirmed that balloon injury of
the rat carotid artery results in vascular smooth mus-
cle cell proliferation and the formation of a thickened
neo-intima, which can be reduced significantly by
thermal pre-conditioning.28 We have shown that,
pretreatment with herbimycin A, significantly reduces
the degree of intimal hyperplasia (IH) and neointimal
proliferation two weeks after balloon injury. Pre-
conditioning with herbimycin A was associated with
increase expression of HSP27 in the endothelium and
medial VSMCs.
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Fig. 4. Carotid arteries from rats given A, drug vehicle B, 18 h post
heat shock and C, from rats given herbimycin A 18 h earlier were
harvested, fixed in formalin, sectioned, and stained with a mono-
clonal anti-HSP27 antibody. The antibody was detected with an
enzyme-conjugated detection system that yields a brown colour in
positive cells. (Original magnification 400) (scale bar 50mm).
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Fig. 5. The intimal area and medial area were measured 14 days
after balloon injury using computerized planimetry and the I/M
ratio was calculated. Graphic representation of I/M ratio 14 days
post balloon injury in the heat shock group and balloon injury alone
group (control) and herbimycin A group.  p5 0.05 vs control
group.
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Vascular injury results in the release of inflamma-
tory mediators and growth factors, such as prosta-
glandins and thromboxane, tumor necrosis factor a
(TNFa), platelet derived growth factor (PDGF) and
fibroblast growth factor (FGF), which activate medial
VSMCs, which in turn migrate and proliferate to form
a thickened neointima.10±13,30 Strategies aimed at
reducing IH have largely focused on limiting VSMC
proliferation post intervention, and have had little
clinical success.7±9 Currently there is interest in
modifying the response of the vessel28 to injury by
pre-conditioning the vasculature prior to the injury.
Thermal pre-conditioning has been shown to diminish
the severity of tissue injury upon subsequent exposure
to a more severe, noxious or injurious stimulus.21±23,31
Induction of the heat shock response in arterial
VSMCs, in vitro, limits proliferation following mech-
anical injury.32 Neischis et al. found that thermal pre-
conditioning prior to vascular injury reduces intimal
hyperplasia.28
Despite the abundance of experimental evidence
demonstrating the benefits of thermal pre-conditioning,
clinicians are understandably reluctant to employ
`` heat shocking'' as a treatment for their patients.
There is currently widespread interest in pharmaco-
logical induction of stress proteins.15 Herbimycin A
is a benzoquinoid ansamycin antibiotic and a known
tyrosine kinase inhibitor. Hedge et al. demonstrated
that treatment of cells with herbimycin A results
in increased expression of all the constitutively
expressed stress proteins and confers a thermotolerant
like phenotype.16 The heat shock protein inducing
effect of herbimycin A has been shown to be inde-
pendent of its tyrosine kinase inhibiting property.16,17
Hedge et al. demonstrated that herbimycin A unlike
heat shock, or other metabolic stressors, did not
induce any adverse cellular effects.16 We investigated
if herbimycin A would induce HSPs in arterial tissue
and whether this induction would confer a protective
effect against the proliferation response of VSMCs
to injury.
We found that HSP70 and HSP27 where maximally
induced 8±18 h post heat shock. Previous work has
demonstrated that the time course for induction of
stress proteins, and the magnitude of this response,
is similar in thermal pre-conditioned and herbimycin A
treated cells.16,17 We have shown that pretreatment
with herbimycin A induces HSP27 in the VSMCs
and endothelium of the arterial wall, but in contrast
to heat shock, herbimycin A did not increase arterial
HSP70. Heat shock has previously been shown to
non-specifically increase an array of HSPs32 whereas
pharmacological induction is more specific.16
Herbimycin A has been suggested to have a cell
type specific effect on some HSPs.16,17 HSP27, a small
stress protein (sHSP), is increased in the myocardium
and VSMCs of spontaneously hypertensive rats.33,34
HSP27 is a molecular chaperone that acts as a
regulator of the intracellular redox state and is a
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Fig. 6. Haematoxylin and eosin stained photomicrographs of rat
carotid artery sections 2 weeks post balloon injury: (A) shows unin-
jured carotid artery; (B) shows injured control artery, (not pre-
treated); (C) shows injured carotid in heat pretreated rat;
(D) shows injured carotid in herbimycin A pretreated rat. (Original
magnification 400) (scale bar 50 mm).
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potent inhibitor of apoptosis.33 Like HSP70, HSP27 is
involved in mediating the protection conferred by
sub-lethal heat shock.36 We have shown for the first
time that arterial HSP27 is increased by both
heat shock and herbimycin A and that both these
treatments limit the degree of IH post balloon injury.
Our results suggest that HSP27 may be the main stress
protein involved in limiting the response of VSMC to
injury. In order to further define the role of HSP70
and HSP27 in limiting VSMC proliferation, in vitro
experiments, using anti-sense oligonucleotides aimed
at blocking HSP70 and HSP27 are required.37
Herbimycin A as well as being a HSP inducer is also
a tyrosine kinase inhibitor. Tyrosine kinase inhibitors
applied topically to the vessel at the time of vascular
intervention, or orally following vascular injury, have
being shown to reduce intimal hyperplasia.38,39 In our
study herbimycin A was given intravenously 18 h
prior to vascular injury and therefore the tyrosine
kinase inhibiting effect of herbimycin A is unlikely to
be responsible for the observed reduction in intimal
hyperplasia.
At present the mechanisms whereby stress proteins
protect the arterial wall from the deleterious effects of
balloon injury can only be inferred. In this arterial
balloon injury model intimal thickening is initiated by
a combination of de-endothelialization, barotrauma
and cell death followed by VSMC activation and pro-
liferation. Indolfi et al. demonstrated that the prolifer-
ation response in this model appears to be directly
proportional to the degree of balloon injury.40 Perlman
and others have recently shown that up to 70% of the
vascular smooth muscle cells in the media undergo
apoptosis at 30 min post balloon injury rat carotid
balloon injury model).41,42 It has been reported that
severe medial VSMC loss occurs in vein grafts even
when prepared without distension with apoptosis
contributing to this loss.43 Inhibition of HSP70 expres-
sion has been shown to stimulate apoptosis and inti-
mal hyperplasia in vein segments in vitro.44 HSP70
and HSP27 have been shown to enhance resistance
to apoptosis in many tissues,37,45±47 this may partially
account for the observed reduction in intimal hyper-
plasia observed in the pre-conditioned groups.
Unfortunately herbimycin A is currently not
licenced for use in humans. There is however increas-
ing evidence to support the future use of herbimycin A
as a pharmacological stress protein inducer in humans,
for example, Hedge et al. in 1995, observed no dele-
terious effects of herbimycin A at the concentrations
used to induce stress protein expression in cells in
culture.16 In this and previous in vivo experiments
we have used a very low dose of herbimycin A as a
pharmacological pre-conditioner, given as a single
intravenous injection 18 h prior to injury to success-
fully attenuate the subsequent inflammatory response.18
Also the dose used in these experiments (400 mg/kg)
was well below the LD50 (19 mg/kg).48 Currently
there is much interest in using other tyrosine kinase
inhibitors to treat chronic myeloid leukaemia.49
Further toxicity studies looking at the effect of herbi-
mycin A in vivo are required before considering the
use of this powerful stress protein inducer in patients
prior to vascular surgery. Currently we are also inves-
tigating the effect of other pharmacological HSP indu-
cers, such as geranylgeranylacetone (teprenone), on
intimal hyperplasia. Teprenone is licenced in Japan
for treating peptic ulcer disease in humans and has
been shown to induce HSPs in the gastric mucosa.50
In summary the current study supports the concept
that thermal pre-conditioning of the vasculature
reduces the subsequent response of the VSMCs to
injury. This study also demonstrates that pharmaco-
logical induction of stress proteins in the vasculature
is possible and results in a similar reduction in the
VSMC proliferation. Our results also suggest that
HSP27 may be the chief stress protein that mediates
the effects of pre-conditioning in the vasculature.
Finally pharmacological HSP inducers may have a
therapeutic role to play in limiting the response of
the vessel wall to injury and thereby reducing the
incidence of re-stenosis post vascular intervention.
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